1. Editor’s commentary

   • John P. Mulhall

   EditorialNotes Pages: 1 - 1

2. The health insurance industry should cover the evaluation and treatment of sexual dysfunction

   • Myron I. Murdock

   Invited Commentary Pages: 2 - 2

3. Web alert

   News Pages: 3 - 4

4. Penile revascularization remains a viable option in the era of oral pharmacotherapy: Pro

   • Yoram Vardi
   • Ilan Gruenwald

   Point/Counterpoint Pages: 5 - 7

5. Penile revascularization remains a viable option in the era of oral pharmacotherapy: Con

   • Eli F. Lizza

   Point/Counterpoint Pages: 8 - 10

6. Erectile dysfunction in the aging male

   • Lizette J. Smith

   OriginalPaper Pages: 13 - 16

7. Contemporary management of penile fracture

   • Emre Akkus

   OriginalPaper Pages: 17 - 20

8. Brachytherapy-associated erectile dysfunction

   • Gregory S. Merrick
   • Wayne M. Butler
   • Kent E. Wallner

   OriginalPaper Pages: 21 - 26

9. Behavioral and psychologic models in ejaculatory function research

   • David L. Rowland
   • Stewart E. Cooper

   OriginalPaper Pages: 29 - 34

10. Evaluation of plasma testosterone: Which test and when?

    • Alex Vermeulen

    OriginalPaper Pages: 37 - 40

11. Controversies regarding testosterone supplementation in the prostate cancer patient

    • Jeffrey P. Bejma
    • Dena Walsh
    • Wayne J. G. Hellstrom

    OriginalPaper Pages: 41 - 44